Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,345.00p
   
  • Change Today:
    -6.00p
  • 52 Week High: 1,530.00
  • 52 Week Low: 1,016.00
  • Currency: UK Pounds
  • Shares Issued: 216.17m
  • Volume: 156,141
  • Market Cap: 2,907.53m
  • RiskGrade: 169

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-19 Interim 138.20 26.00 13.20p 3.55p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-15 144.03 46.10 19.89p 26.0 2.6 +10% 8.21p 1.6%
30-Jun-16 171.67 45.41 22.45p 34.3 2.6 +13% 8.91p 1.2%
30-Jun-17 217.10 51.87 25.66p 37.9 2.7 +14% 10.18p 1.0%
30-Jun-18 233.20 69.10 32.70p 40.8 1.5 +27% 12.00p 0.9%
30-Jun-19 259.90 56.40 32.90p 44.8 44.8 +1% 12.13p 0.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 258.49 51.34 21.04p 63.9 n/a -36% 10.43p 0.7%
30-Jun-21 301.62 69.87 27.19p 49.5 1.7 +29% 9.14p 0.7%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 26.04 26.04 36.78 1.11

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Abcam Market Data

Currency UK Pounds
Share Price 1,345.00p
Change Today -6.00p
% Change -0.44 %
52 Week High 1,530.00
52 Week Low 1,016.00
Volume 156,141
Shares Issued 216.17m
Market Cap 2,907.53m
RiskGrade 169

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average32.60% above the market average
15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average
Income
98.38% below the market average98.38% below the market average98.38% below the market average98.38% below the market average98.38% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 3
Sell 0
Strong Sell 2
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 03-Jul-2020

Time Volume / Share Price
17:13 6,673 @ 1,348.04p
16:35 76,017 @ 1,345.00p
16:29 15 @ 1,343.00p
16:29 7 @ 1,343.00p
16:29 58 @ 1,343.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page